314741-39-4 Usage
Uses
Used in Pharmaceutical Synthesis:
(S)-4-N-Boc-piperazine-2-carboxylic acid methyl ester is used as a key intermediate for the synthesis of various pharmaceuticals. Its unique structure and reactivity allow for the development of bioactive molecules with potential therapeutic applications.
Used in Organic Chemistry:
In the field of organic chemistry, (S)-4-N-Boc-piperazine-2-carboxylic acid methyl ester serves as a building block for the preparation of diverse organic compounds. Its versatile reactivity enables the synthesis of a wide range of molecules with different functional groups and properties.
Used in Medicinal Chemistry:
(S)-4-N-Boc-piperazine-2-carboxylic acid methyl ester is utilized as a starting material in the design and synthesis of new bioactive molecules with potential pharmacological activities. Its unique structure allows for the exploration of novel drug candidates for various therapeutic areas.
Used in Chemical Research:
As a chemical compound with interesting properties, (S)-4-N-Boc-piperazine-2-carboxylic acid methyl ester is employed in research studies to investigate its reactivity, stability, and potential applications in various chemical processes.
It is important to handle and store (S)-4-N-Boc-piperazine-2-carboxylic acid methyl ester with proper safety precautions and in accordance with chemical handling guidelines to ensure the safety of researchers and the environment.
Check Digit Verification of cas no
The CAS Registry Mumber 314741-39-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,1,4,7,4 and 1 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 314741-39:
(8*3)+(7*1)+(6*4)+(5*7)+(4*4)+(3*1)+(2*3)+(1*9)=124
124 % 10 = 4
So 314741-39-4 is a valid CAS Registry Number.
InChI:InChI=1/C11H20N2O4/c1-11(2,3)17-10(15)13-6-5-12-8(7-13)9(14)16-4/h8,12H,5-7H2,1-4H3/t8-/m1/s1
314741-39-4Relevant articles and documents
SATURATED BICYCLIC HETEROCYCLIC DERIVATIVES AS SMO ANTAGONISTS
-
Page/Page column 41, (2010/04/06)
The present invention relates to compounds of formula I: and pharmaceutically acceptable salts or tautomers thereof which are inhibitors of the Sonic Hedgehog pathway, in particular Smoantagonists. Thus the compounds of this invention are useful for the treatment of diseases associated with abnormal hedgehog pathway activation, including cancer, for example basal cell carcinoma, medulloblastoma, prostate, pancreatic, breast, colon, bone and small cell lung cancers, and cancers of the upper GI tract.
QUINOLINE DERIVATIVES AS ANTIBACTERIALS
-
Page 12, (2010/02/06)
The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt and/or N-oxide thereof: corresponding novel medicaments, pharmaceutical compositions and/or methods of
Compounds and methods for the treatment of neoplastic disease
-
, (2008/06/13)
A method of modulating the activity of a aberrant cell topoisomerase enzyme involving contacting the enzyme with a compound that inhibits enzyme-mediated cleavage of a polynucleotide substrate with which the enzyme is in complex. Pharmaceutical compositions containing such compounds may be used to treat neoplasias or to inhibit the growth of certain cancer cells. Screening methods can be employed to identify other compounds for these uses.
